Analytical Data
-
基因名
SAGE1
- Application
-
别名
Cancer/testis antigen 14; CT14; RP11-97N5.1; SAGE; SAGE1; SAGE1_HUMAN; Sarcoma antigen 1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NXZ1
-
表达区间
357-455 aa
-
氨基酸序列
PLPSNALSTVLPGLAYLATADMPAMSTRDQHATIIHNLREEKKDNSQPTPDNVLSAVTPELINLAGAGIPPMSTRDQYATVNHHVHEARMENGQRKQDN
-
分子量
36.63 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SAGE1, a protein associated with the diagnosis and treatment of various diseases, has garnered significant attention in recent years due to its unique structural features and functional roles in cellular processes. Research indicates that SAGE1 may play a critical role in cell signaling, apoptosis, and immune response, making it a potential target for therapeutic interventions. Its involvement in pathological conditions, such as cancer and autoimmune disorders, highlights the importance of understanding SAGE1's mechanisms of action. Recent advancements in recombinant protein technology have enabled the production and characterization of SAGE1, allowing researchers to explore its biological functions in detail. Moreover, studies on SAGE1 have led to the development of specific inhibitors and biomarker applications, thus paving the way for innovative strategies in drug discovery and personalized medicine. The ongoing research on SAGE1 not only provides insights into its biological significance but also opens new avenues for potential clinical applications, emphasizing the need for continued exploration of this intriguing protein.
